Connect with us

COVID-19

Nigeria Expects 29million Doses of J&J COVID Vaccine in August

Published

on

Nigeria Expects 29million Doses of J&J COVID Vaccine in August

Nigeria expects to take delivery of 29 million doses of Johnson & Johnson covid-19 vaccine in August, allowing it to ramp up its vaccination programme just as a third wave of infections takes hold, the health minister said.

Health Minister Osagie Ehanire told reporters on Monday, that the single-dose vaccine would be advantageous for Nigeria, given its partly nomadic population and weak systems for keeping track of people and arranging for second doses.

Ehanire said Nigeria was also expecting four million doses of the Moderna vaccine, 700,000 doses of the AstraZeneca vaccine and an unspecified quantity of Pfizer and Sinopharm doses. He said all of those were expected in the third quarter.

The minister also warned that the covid-19 infection numbers were rising due to the spread of the highly contagious Delta variant, noting that 216 people had tested positive in the last 24 hours, most of them in Lagos and Akwa Ibom.

Follow us on Facebook
With an estimated 200 million citizens, Nigeria has so far vaccinated a tiny fraction of its population. The most recent data, in June, showed that 2 million people had received one dose and 700,000 had received two. In total, Nigeria has so far taken delivery of under 4 million doses.

The government had announced in March it was hoping to secure 70 million doses of Johnson and Johnson vaccine this year through an African Union programme, with an initial batch of 30 million to be delivered in the third quarter.

Read Also:

Nigeria’s D’tigers Outclass Argentina 94-71 In Exhibition Game

NAFDAC gives reason for not approving herbal treatment for Covid-19

 

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19

U.S Approves Pfizer COVID Booster for The Elderly and High-Risk

Published

on

U.S Approves Pfizer COVID Booster for The Elderly and High-Risk

The U.S has authorised the administration of boosters of the Pfizer-Biontech Covid-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.

The announcement means a significant part of the US population – amounting to tens of millions of Americans – are now eligible for a third shot six months after their second.

The decision was expected and came after an independent expert panel convened by the regulatory agency last week voted in favour of recommending the move.

Watch Our Youtube Videos

The panel, however, rejected an initial plan by the white house to fully approve Pfizer boosters for everyone aged 16 and over, in what amounted to a rare rebuke of President Joe Biden’s administration.

Pfizer Covid-19 boosters are currently being debated by a separate body of experts convened by the centers for disease control and prevention, which may recommend further specifics about recipients of the vaccine.

Read Also:

President Biden Pledges 500m More Vaccine Doses to Developing World

Japan Detects More Moderna Vaccine Contamination

 

Continue Reading

COVID-19

India Resumes Export of Covid-19 Vaccine from October

Published

on

India Resumes Export of Covid-19 Vaccine from October

India will resume exporting Covid-19 vaccines from October, five months after it stopped sending supplies abroad in the face of a deadly wave of infections, the health minister said on Monday.

The world’s largest vaccine producer had halted exports in April, when a virus surge in India pushed the healthcare system to breaking point and there was a huge demand for jabs.

Health Minister Mansukh Mandaviya said more than 300 million vaccine doses would be produced in October and one billion in the last three months of the year.

Follow us on Facebook

“India will be resuming export of vaccines in order to fulfill the commitment of India towards Covax. The surplus supply of vaccines will be used to fulfill our commitment towards the world for the collective fight against Covid-19”, Mandaviya said in a statement.

India wants to vaccinate its adult population by the end of 2021. It has given more than 818 million doses of the three approved jabs since the beginning of the vaccination drive in January. On Friday, it administered a record-breaking 20 million doses, surpassing the country’s previous best daily tally of more than 13 million jabs on 27 August.

Read Also:

Court Orders Resident Doctors to Call Off Strike

AU Rolls Out 400m Vaccine Doses to Member States

Continue Reading

COVID-19

Pfizer Says Its Covid-19 Jab Safe for Children Aged 5-11

Published

on

Pfizer Says Its Covid-19 Jab Safe for Children Aged 5-11

Pfizer and Biontech on Monday said trial results showed their Coronavirus vaccine was safe and produced a robust immune response in children aged five to 11, adding that they would seek regulatory approval shortly.

The vaccine would be administered at a lower dosage than for people over 12, they said.

They plan to submit their data to regulatory bodies in the European Union, the united states and around the world “as soon as possible”.

Follow us on Facebook

The trial results are the first of their kind for children under 12, with a Moderna trial for six-11-year-olds still ongoing.

Both the Pfizer and Moderna jabs are already being administered to adolescents over 12 and adults in countries around the globe.

Although children are considered less at risk of severe cases of Covid-19, there are concerns that the highly contagious delta variant could lead to more serious cases.

Inoculating children is also seen as key to keeping schools open and helping end the pandemic.

Read Also:

Nigerian Doctor Helps Pfizer Develop First Effective COVID-19 Vaccine

NPHCDA Begins Online Registration Of Nigerians For COVID-19 Vaccination

Continue Reading

Trending